On News of Illumina Bid, Solexa Shares Climb 29 Percent as Illumina's Dive 13 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Shares in Solexa were up 29 percent and shares in Illumina were down 13 percent in midday trading after Illumina said this morning it plans to buy Solexa for roughly $600 million in stocks.
 
Solexa was trading up $2.83 a share at $12.51 while Illumina was trading down $5.75 at $38.28.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.